Lung-restricted ALK5 inhibition avoids systemic toxicities associated with TGFß pathway inhibition.
Toxicol Appl Pharmacol
; 438: 115905, 2022 03 01.
Article
in En
| MEDLINE
| ID: mdl-35122773
Full text:
1
Database:
MEDLINE
Main subject:
Signal Transduction
/
Receptor, Transforming Growth Factor-beta Type I
/
Lung
Type of study:
Risk_factors_studies
Limits:
Animals
Language:
En
Year:
2022
Type:
Article